ProfileGDS5822 / ILMN_3034820
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 31% 46% 12% 23% 4% 37% 22% 18% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 115.731
GSM1276600PDAC Late Ablation Control 222.546
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.412
GSM1276603PDAC Late Ablation 212.923
GSM1276604PDAC Late Ablation 35.14
GSM1303940PDAC Late Ablation_anti-CTLA4 117.637
GSM1303941PDAC Late Ablation_anti-CTLA4 211.722
GSM1303942PDAC Late Ablation_anti-CTLA4 31018